.avif)
.svg)
Our Story
Our capabilities span foundational research to the complete advanced therapy manufacturing continuum, from cellular starting materials, plasmid DNA, and viral vector production, through cell therapy manufacturing, all with industry-leading timelines. We have decades of expertise in delivering cellular starting materials and viral vector production and have been a trusted provider of plasmid DNA manufacturing since 1992. Rose BioSolutions is proud to offer the full continuum of capabilities as part of a single, comprehensive offering, as well as demonstrated commercial supply to both the US and EU, eliminating the supplier handoffs and knowledge gaps where programs stall.
We have a world-class team of experts supporting clients at every step of the therapy manufacturing process. Our scientists are constantly driving innovation for advanced therapy starting materials. Our manufacturing experts don’t wait for a tech transfer package. They enter programs at the design stage, co-authoring regulatory strategy and leveraging decades of experience to refine processes mid-development, all while maintaining critical continuity and global compliance from first clinical batch through commercial production.
We have the infrastructure and capital to scale alongside every program in our pipeline. The capacity is already in place, with established capabilities that span basic research to complete advanced therapies. As Rose BioSolutions, we are built to expand technical and scientific capabilities, invest in infrastructure and capacity, and deepen collaboration with clients across programs.
